Foresight Diagnostics - Ketryx

How Foresight Diagnostics Reduced Documentation Time by 80%

Foresight Diagnostics is a biotechnology company developing advanced diagnostic tools for detecting minimal residual disease (MRD) in cancer patients. The company leverages cutting-edge genomic and molecular techniques to provide highly sensitive diagnostic tests, which can help in monitoring recurrence. These diagnostics will have the opportunity to improve personalized cancer treatment by enabling clinicians to make informed decisions about patient care based on precise and early detection of residual disease. Foresight accelerated their release cycles with Ketryx by decreasing documentation time by 80% and onboarding developers more quickly, all of which helps them get their life-saving product to market faster.

Impact

80%

Reduction in documentation time

62304

Full support for IEC 62304 compliance

Industry
BioTech
Device Type
Cancer Diagnostic
Tech Stack
Jira, GitHub

Customer pain points

Manual documentation delayed release cycles

Before Ketryx, the Foresight team spent days per release on highly manual documentation, which delayed their release cycles.

The Ketryx solution

IEC 62304 compliance, automatically

Foresight Diagnostics sought a solution to streamline SDLC management and selected Ketryx to achieve the following objectives:

Business outcomes

Documenting, developing, and onboarding faster

With Ketryx, the Foresight team quickly realized several key benefits:

"I used a traditional ALM in the past and it didn’t have the traceability I needed, especially tracing from my test executions and results. It also created duplicate work since I needed to go update my work there every time I completed a task. Ketryx updates itself as I’m working in Jira and GitHub. This tighter integration into our current tools helps us be more productive and release faster."

Aaron Berlin
SVP Development and Engineering

Are You Building Medical Software?
Get started building software in minutes, not months.